KISUNLA
Live / Registered — Registered (as of 24 Jun 2025)
What this means for you
Registered since 24 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90761518
- Registration number
- 7844630
- Mark type
- Stylized text
- Filed
- 08 Jun 2021
- Published for opposition
- 22 Feb 2022
- Registered
- 24 Jun 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, central nervous system diseases and disorders, dementia, mental disorders, neurodegenerative diseases and disorders, and neurological disorders
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 24 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jun 2025 — ASSIGNED TO EXAMINER
- 07 Aug 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Aug 2024 — USE AMENDMENT FILED
- 05 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2024 — SOU EXTENSION 4 GRANTED
- 14 Mar 2024 — SOU EXTENSION 4 FILED
- 14 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 20 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2023 — SOU EXTENSION 3 GRANTED
- 18 Sept 2023 — SOU EXTENSION 3 FILED